Erenumab-Aooe
Brand name: Aimovig Autoinjector
Rank #144 of 500 drugs by total cost
$111.9M
Total Cost
118,455
Total Claims
$111.9M
Total Cost
3,575
Prescribers
$944
Cost per Claim
9,119
Beneficiaries
143,066
30-Day Fills
$31K
Avg Cost/Provider
33
Avg Claims/Provider
About Erenumab-Aooe
Erenumab-Aooe (sold as Aimovig Autoinjector) was prescribed 118,455 times by 3,575 Medicare Part D providers in 2023, costing the program $111.9M. At $944 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 141 | Estradiol (Estradiol) | $115.7M | 1,412,386 |
| 142 | Vortioxetine Hydrobromide (Trintellix) | $113.9M | 197,873 |
| 143 | Asfotase Alfa (Strensiq) | $113.8M | 1,142 |
| 144 | Erenumab-Aooe (Aimovig Autoinjector) | $111.9M | 118,455 |
| 145 | Corticotropin (Acthar) | $111.6M | 1,633 |
| 146 | Bupropion Hcl (Bupropion Hcl Sr) | $110.0M | 3,323,724 |
| 147 | Dimethyl Fumarate (Dimethyl Fumarate) | $109.8M | 29,208 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology